101 related articles for article (PubMed ID: 28202613)
1. The Activating Human NK Cell Receptor KIR2DS2 Recognizes a β
Thiruchelvam-Kyle L; Hoelsbrekken SE; Saether PC; Bjørnsen EG; Pende D; Fossum S; Daws MR; Dissen E
J Immunol; 2017 Apr; 198(7):2556-2567. PubMed ID: 28202613
[TBL] [Abstract][Full Text] [Related]
2. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
3. A novel antibody combination to identify KIR2DS2
Blunt MD; Rettman P; Bastidas-Legarda LY; Fulton R; Capizzuto V; Naiyer MM; Traherne JA; Khakoo SI
HLA; 2019 Jan; 93(1):32-35. PubMed ID: 30381896
[TBL] [Abstract][Full Text] [Related]
4. Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors.
Warren HS; Campbell AJ; Waldron JC; Lanier LL
Int Immunol; 2001 Aug; 13(8):1043-52. PubMed ID: 11470774
[TBL] [Abstract][Full Text] [Related]
5. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3.
Moesta AK; Parham P
Front Immunol; 2012; 3():336. PubMed ID: 23189078
[TBL] [Abstract][Full Text] [Related]
6. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
7. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
[TBL] [Abstract][Full Text] [Related]
8. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
[TBL] [Abstract][Full Text] [Related]
9. Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.
Moradi S; Stankovic S; O'Connor GM; Pymm P; MacLachlan BJ; Faoro C; Retière C; Sullivan LC; Saunders PM; Widjaja J; Cox-Livingstone S; Rossjohn J; Brooks AG; Vivian JP
Nat Commun; 2021 Apr; 12(1):2173. PubMed ID: 33846289
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
11. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2.
Vitale M; Carlomagno S; Falco M; Pende D; Romeo E; Rivera P; Della Chiesa M; Mavilio D; Moretta A
Int Immunol; 2004 Oct; 16(10):1459-66. PubMed ID: 15314042
[TBL] [Abstract][Full Text] [Related]
13. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
[TBL] [Abstract][Full Text] [Related]
14. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
[TBL] [Abstract][Full Text] [Related]
15. Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease.
Ayo CM; Reis PG; Dalalio MM; Visentainer JE; Oliveira Cde F; de Araújo SM; de Oliveira Marques DS; Sell AM
PLoS Negl Trop Dis; 2015 May; 9(5):e0003753. PubMed ID: 25978047
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.
Hollenbach JA; Ladner MB; Saeteurn K; Taylor KD; Mei L; Haritunians T; McGovern DP; Erlich HA; Rotter JI; Trachtenberg EA
Immunogenetics; 2009 Oct; 61(10):663-71. PubMed ID: 19789864
[TBL] [Abstract][Full Text] [Related]
17. Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation.
Martínez-Losada C; Martín C; Gonzalez R; Manzanares B; García-Torres E; Herrera C
Front Immunol; 2017; 8():810. PubMed ID: 28751893
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j).
Saulquin X; Gastinel LN; Vivier E
J Exp Med; 2003 Apr; 197(7):933-8. PubMed ID: 12668644
[TBL] [Abstract][Full Text] [Related]
19. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
Falco M; Romeo E; Marcenaro S; Martini S; Vitale M; Bottino C; Mingari MC; Moretta L; Moretta A; Pende D
J Immunol; 2010 Jul; 185(1):433-41. PubMed ID: 20525888
[TBL] [Abstract][Full Text] [Related]
20. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]